Skip to main content

Table 1 Patient demographics and clinical characteristics

From: Chronic opioid use following surgery for head and neck cancer patients undergoing free flap reconstruction

Clinical Characteristic

Patients N = 212 (%)

Preoperative Opioid-Naïve

Preoperative Opioid Use

p value

Total

n = 127 (60%)

n = 85 (40%)

 

Gender

0.046

 Male

96 (76%)

53 (62%)

 

 Female

31 (24%)

32 (38%)

 

Age (years)

0.8

 Mean [SD]

61.2 [13.81]

60.6 [12.66]

 

 Range

19.5–89.8

23.4–86.6

 

Social Habits

 

 Prior Tobacco

89 (70%)

59 (69%)

1.0

 Prior Alcohol

87 (69%)

58 (68%)

0.8

Clinical Stage

0.05

 In Situ (Stage 0)

2 (2%)

1 (1%)

 

 I

11 (9%)

15 (18%)

 

 II

26 (20%)

13 (15%)

 

 III

15 (12%)

13 (15%)

 

 IV

65 (51%)

43 (51%)

 

 Other

8 (6%)

0 (0%)

 

Primary Tumour Location

0.04

 Oral Cavity

102 (80%)

62 (73%)

 

 Salivary Gland

4 (3%)

8 (9%)

 

 Paranasal Sinus

4 (3%)

8 (9%)

 

 Other

17 (13%)

7 (8%)

 

Free Flap

1.0

 Soft Tissue

95 (75%)

64 (75%)

 

 Bone

23 (18%)

16 (19%)

 

 Soft Tissue + bone

9 (7%)

5 (6%)

 

Treatment

0.6

 Surgery Alone

53 (42%)

39 (46%)

 

 Surgery + Adjuvant

74 (58%)

46 (54%)